Thomas Lingelbach

Thomas Lingelbach, President & Chief Executive Officer, Valneva. He was CEO of Intercell and founding CEO of Valneva. He is an established vaccine industry leader with breadth of experience. Prior to Valneva, Thomas had senior & executive management roles with Intercell, Novartis and Chiron. During his 30 years in vaccines, he held a variety of positions from product development to commercialization with a strong emphasis on technical development & operations. In different capacities, he contributed to the successful development and licensure of more than ten vaccines. Thomas Lingelbach holds an engineering degree, specialized in bioprocess engineering. He complemented his education with a business administration program. He is a German national, born in 1963.